
Malawi’s cholera outbreak sustained through winter
Malawi’s cholera outbreak in March 2022 came at the end of rainy season. However, as the disease continues to claim lives it is thought that the damage caused by tropical storms is partly to blame. Head of Public Health at Kamuzu University of Health Sciences,...

Bavarian Nordic capacity increased with US manufacturer
Bavarian Nordic announced in August 2022 that it had “entered into an agreement” with Grand River Aseptic Manufacturing (GRAM) to expand capacity for the delivery of monkeypox vaccines to the US. GRAM is a US based manufacturer with an FDA approved facility. The US...

GSK awarded malaria vaccine contract by UNICEF
The pharmaceutical company GSK was awarded a contract for the first supply of a malaria vaccine by UNICEF in 2022. The contract has a value of up to $170 m
MOST POPULAR THIS MONTH



UNITAID’s “Landscape” of tools and strategies
UNITAID published a report in August 2022 to examine the “landscape of tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis B, and Chagas. Mother-to-child transmission is also known as vertical transmission. The report...



UK’s first human Brucella canis case confirmed
The European Scientific Counsel Companion Animal Parasites (ESCCAP) called for compulsory testing of imported dogs after the UK’s first case of dog-to-human transmission of Brucella canis (B canis). This causes an infectious disease called canine brucellosis, with a...



WHO updates guidance for Tuberculosis response
In August 2022 the WHO announced new guidance to “support national strategic planning” for tuberculosis (TB) responses. This guidance was described as a culmination of the “latest WHO guidelines” by Dr Tereza Kasaeva, Director of WHO’s Global Tuberculosis Programme. ...



UK’s JCVI updates Covid-19 booster programme
In August 2022 the UK's Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will be used for each group in autumn. The JCVI emphasised that every option on the list provides protection against “severe illness” from Covid-19....




White paper from IDT Biologika: oncolytic viruses
In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing oncolytic viruses and how to avoid problems. Oncolytic viruses (OVs) have the “potential to revolutionise standard cancer treatment”. Researchers continue to...



mRNA vaccine for cancer shows promise at Tufts University
A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes instead of the liver. Researchers at Tufts School of Engineering believe that this method is “so strong and precise, it eliminates tumours and even prevents their...



Avian influenza restrictions lifted in the UK
In August 2022 the UK’s Chief Veterinary Office, Professor Christine Middlemiss, appealed to bird keepers to maintain enhanced biosecurity measures after an avian influenza outbreak. Restrictions lifted on 16th August, but Professor Middlemiss is keen to ensure that...



UK approves Moderna’s dual vaccine against Covid
The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced in August 2022 that it approved Moderna’s bivalent vaccine, Spikevax Bivalent Original/Omicron, against two forms of Covid. Dr June Raine, chief executive of the MHRA, stated that the “first...
LATEST
University partners find MND therapy potential
Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of motor neurons”.
White paper from IDT Biologika: viral vectors
In a white paper Dr Neubert explores how viral vectors offer a host of opportunities for vaccine development with the right conditions and collaboration.
Study reveals Covid-19 vaccinations safe for pregnancy
A study published in The Lancet in August 2022 concluded that Covid-19 vaccinations had a “good safety profile”. This was concluded during an attempt…
CEPI driving research into monkeypox vaccines
In July CEPI announced that it would provide $375,000 to “support the development of key laboratory tools to advance and standardise assessment of vaccines”.
Professor Hotez warns against anti-vaccine activism
In August 2022 Dr Peter Hotez wrote an article in Nature exploring the dire consequences of America’s “anti-vaccine activism”
Langya (LayV) henipavirus emerges in China
Langya (LayV) is a henipavirus. According to an article in New Scientist it appears to be “most closely related to Mojiang henipavirus”
VIDEOS
World Vaccine Congress Europe 2022 trailer!
We are thrilled to share this short video teasing the World Vaccine Congress in Europe, 2022! To get your tickets click here.
World Vaccine Congress 2022 Washington reel!
This short video reviews our previous World Vaccine Congress in Washington, 2022. We are already preparing for the 2023 World Vaccine Congress; to buy your tickets follow this link!
World Vaccine Congress 2020 invitation!
This short video features an invitation to the World Vaccine Congress in Europe, 2020. We are already preparing for the 2022 World Vaccine Congress; to buy your tickets follow this link!
World Vaccine Congress Washington 2019 trailer!
This short video shows our previous World Vaccine Congress in Washington, 2019. We are already preparing for the 2023 World Vaccine Congress
THERAPEUTIC



mRNA vaccine for cancer shows promise at Tufts University
A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes instead of the liver. Researchers say this method is “strong”


University partners find MND therapy potential
Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of motor neurons”.


Tired T-cells need TLC to continue fighting cancer
When providing an immune response to cancer T-cells are known to get “exhausted” to the point of no return. Early exhaustion can sometimes be reversed


Immune system map uncovers therapeutic potential
A group of scientists, led by researchers at the Wellcome Sanger Institute and ETH Zurich, created a “comprehensive map” of the connections…


Improving protein factories for gene therapies
Gene therapy tackles the source of disease in the patient’s DNA through viral or bacterial vectors. Most commonly, muscle cells are targeted
TECHNOLOGY


Bavarian Nordic capacity increased with US manufacturer
Bavarian Nordic announced in August 2022 that it had “entered into an agreement” with GRAM to expand capacity for the delivery of monkeypox vaccines to the US



UNITAID’s “Landscape” of tools and strategies
UNITAID published a report to examine the “tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis B, and Chagas.




White paper from IDT Biologika: oncolytic viruses
In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing oncolytic viruses and how to avoid problems.




White paper from IDT Biologika: viral vectors
In a white paper Dr Neubert explores how viral vectors offer a host of opportunities for vaccine development with the right conditions and collaboration.


CEPI driving research into monkeypox vaccines
In July CEPI announced that it would provide $375,000 to “support the development of key laboratory tools to advance and standardise assessment of vaccines”.
INFECTION



UK’s first human Brucella canis case confirmed
The European Scientific Counsel Companion Animal Parasites called for compulsory testing of imported dogs after the UK’s first case of dog-to-human transmission



WHO updates guidance for Tuberculosis response
In August 2022 the WHO announced new guidance to “support national strategic planning” for TB responses. This guidance is a culmination of “latest guidelines”



UK’s JCVI updates Covid-19 booster programme
In August 2022 the Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will be used for each group in autumn.



Avian influenza restrictions lifted in the UK
The UK’s Chief Veterinary Office, Professor Christine Middlemiss, is appealing to bird keepers to maintain enhanced biosecurity measures.



UK approves Moderna’s dual vaccine against Covid
The UK Medicines and Healthcare products regulatory Agency (MHRA) announced in August that it had approved Moderna’s bivalent vaccine
GLOBAL HEALTH



GSK awarded malaria vaccine contract by UNICEF
The pharmaceutical company GSK was awarded a contract for the first supply of a malaria vaccine by UNICEF in 2022. The contract has a value of up to $170 m


Malawi’s cholera outbreak sustained through winter
The beginning of Malawi’s cholera outbreak in March 2022 came at the end of rainy season. A spokesperson for the Ministry of Health suggested that cases vary.


Study reveals Covid-19 vaccinations safe for pregnancy
A study published in The Lancet in August 2022 concluded that Covid-19 vaccinations had a “good safety profile”. This was concluded during an attempt…


Professor Hotez warns against anti-vaccine activism
In August 2022 Dr Peter Hotez wrote an article in Nature exploring the dire consequences of America’s “anti-vaccine activism”


Positive partnerships for malaria prevention
Malaria threatens almost half of the world’s population, with the WHO estimating that the number of deaths in 2020 reached 627,000.